No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Yuekang Pharmaceutical: 2024 Annual Results Express Announcement
2024 Annual Results Express Announcement
Youcare Pharmaceutical Group (688658.SH): The net income for 2024, excluding non-recurring items, is 0.11 billion yuan, a decrease of 16.33% year-on-year.
Glory Financial reported on February 27 that Youcare Pharmaceutical Group (688658.SH) announced its performance flash report for the fiscal year 2024. In the fiscal year 2024, the company achieved total operating revenue of 3,780.876 million yuan, a decrease of 9.90% compared to the same period last year; realized operating profit of 159.0629 million yuan, a decrease of 31.37% compared to the same period last year. The net income attributable to the owners of the parent company, after deducting non-recurring gains and losses, was 110.7587 million yuan, a decrease of 16.33% compared to the same period last year; as of December 31, 2024, the company's total assets were 5,738.1124 million yuan, a decrease of 2.9% compared to the beginning of the year.
Are Poor Financial Prospects Dragging Down Youcare Pharmaceutical Group Co., Ltd. (SHSE:688658 Stock?
Youcare Pharmaceutical Gets US FDA Green Light For Lower Respiratory Tract Disease Vaccine Trial
Some Confidence Is Lacking In Youcare Pharmaceutical Group Co., Ltd. (SHSE:688658) As Shares Slide 26%
